Blood cancers such as leukemia, lymphoma, and myeloma often begin in the bone marrow and disrupt normal blood cell formation.

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

When cancer cells are physically squeezed, they mount an instant, high-energy defense by rushing mitochondria to the cell ...

Rather than working on the surface of cells like some cancer medicines, small molecules are able to slip inside the cell to ...

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...

Providence Cancer Institute’s executive medical director, Bryan Bell, M.D., D.D.S, FACS, FRCS(Ed), recently discussed recent ...

Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it ...